One-Time Solution to Heart Disease? Eli Lilly’s Gene Therapy Says Yes | Vantage on Firstpost | 4K
Fast food like burgers, pizzas, shawarmas, and instant noodles may feel comforting, but they can quietly contribute to rising bad cholesterol and long-term heart risks. LDL cholesterol builds up silently in arteries, increasing the chance of heart disease without obvious warning signs. Scientists are now testing a futuristic one-time gene-editing treatment developed by Verve Therapeutics, a subsidiary of Eli Lilly, called VERVE-102. It targets the PCSK9 gene, which controls how the liver removes cholesterol. Using base editing and lipid nanoparticles, the therapy switches off this gene. Early trials show major LDL reductions, but safety concerns remain under further study.---
Bad Cholesterol | LDL Cholesterol | Fast Food Health Risks | Heart Disease | Gene Editing Treatment | Verve Therapeutics | Eli Lilly | VERVE 102 | PCSK9 Gene | Cholesterol Treatment | High Cholesterol | Heart Health | Gene Therapy | Firstpost | World News | News Live | Vantage | Hem Saroya | News
#cholesterol #ldl #heartdisease #fastfood #healthnews #geneediting #vervetherapeutics #elililly #firstpost #vantageonfirstpost #hemsaroya #worldnews
Vantage is a ground-breaking news, opinions, and current affairs show from Firstpost. Catering to a global audience, Vantage covers the biggest news stories from a 360-degree perspective, giving viewers a chance to assess the impact of world events through a uniquely Indian lens.
By breaking stereotypes, Vantage aims to challenge conventional wisdom and present an alternative view on global affairs, defying the norm and opening the door to new perspectives. The show goes beyond the headlines to uncover the hidden stories – making Vantage a destination for thought-provoking ideas.
Vantage airs Monday to Friday at 9 PM IST on Firstpost across all leading platforms.
Subscribe to Firstpost channel and press the bell icon to get notified when we go live.
https://www.youtube.com/@Firstpost
Follow Firstpost on Instagram:
https://www.instagram.com/firstpost/
Follow Firstpost on Facebook:
https://www.facebook.com/firstpostin/
Follow Firstpost on Twitter:
https://twitter.com/firstpost
Follow Firstpost on WhatsApp:
https://www.whatsapp.com/channel/0029Va6zOIrEQIamseyg762V Receive SMS online on sms24.me
TubeReader video aggregator is a website that collects and organizes online videos from the YouTube source. Video aggregation is done for different purposes, and TubeReader take different approaches to achieve their purpose.
Our try to collect videos of high quality or interest for visitors to view; the collection may be made by editors or may be based on community votes.
Another method is to base the collection on those videos most viewed, either at the aggregator site or at various popular video hosting sites.
TubeReader site exists to allow users to collect their own sets of videos, for personal use as well as for browsing and viewing by others; TubeReader can develop online communities around video sharing.
Our site allow users to create a personalized video playlist, for personal use as well as for browsing and viewing by others.
@YouTubeReaderBot allows you to subscribe to Youtube channels.
By using @YouTubeReaderBot Bot you agree with YouTube Terms of Service.
Use the @YouTubeReaderBot telegram bot to be the first to be notified when new videos are released on your favorite channels.
Look for new videos or channels and share them with your friends.
You can start using our bot from this video, subscribe now to One-Time Solution to Heart Disease? Eli Lilly’s Gene Therapy Says Yes | Vantage on Firstpost | 4K
What is YouTube?
YouTube is a free video sharing website that makes it easy to watch online videos. You can even create and upload your own videos to share with others. Originally created in 2005, YouTube is now one of the most popular sites on the Web, with visitors watching around 6 billion hours of video every month.
